Clarivate(CLVT)
搜索文档
Clarivate Appoints Former ProQuest CEO Matti Shem Tov as the Company's Next CEO
Prnewswire· 2024-08-06 18:01
Chief Executive Jonathan Gear to Step Down as CEO and Member of the Board LONDON, Aug. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that the Board has appointed Matti Shem Tov, former CEO of ProQuest, as the Company's next CEO, effective August 9, 2024. Mr. Shem Tov will also join the Company's Board of Directors. Jonathan Gear, Chief Executive Officer, will step down as CEO and as a member of the Board at that time, and will t ...
Clarivate Reports Second Quarter 2024 Results
Prnewswire· 2024-08-06 18:00
— Reaffirms 2024 Outlook — LONDON, Aug. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Revenues of $650.3 million decreased 2.8% Organic revenues decreased 0.6%, as an increase in subscription revenues of 0.7% was offset by a decrease in re-occurring revenues of 0.7% and transactional and other revenues of 4. ...
Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence
Prnewswire· 2024-07-30 15:00
Empowering biopharma with enhanced safety insights to anticipate risks and unlock new competitive advantages The new platform features an upgraded technology stack and enhanced functionality while retaining its core capabilities. These improvements include an 80% reduction in loading times for targets, drugs, drug combinations and adverse events. The platform now offers faster search capabilities, a clearer visual design, full-screen visualization and additional analytic tools. OFF-X empowers users to monit ...
Clarivate Director Richard Roedel to Retire from Board of Directors
Prnewswire· 2024-07-24 19:30
LONDON, July 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Richard Roedel will retire from the Board of Directors (the "Board") for health reasons, effective December 31, 2024. The Board expects Valeria Alberola, a member of the Board since May 2021, and a member of its Audit and Finance Committees, to succeed Mr. Roedel as Chair of the Audit Committee. Ms. Alberola brings over 25 years of global experience in corporate fi ...
Clarivate Director Richard Roedel to Retire from Board of Directors
Prnewswire· 2024-07-24 19:30
文章核心观点 - Clarivate Plc宣布董事会成员Richard Roedel将于2024年12月31日退休,Valeria Alberola将接任审计委员会主席 [1][2] - Valeria Alberola拥有25年以上的全球企业财务、投资银行、可持续投资、运营和战略管理咨询经验 [3] - Valeria Alberola曾担任Zoma Holdings LLC首席执行官、Bridge Education Group Inc.首席财务官,以及Q Advisors LLC合伙人 [3] 公司概况 - Clarivate是一家领先的全球转型情报提供商,在学术与政府、知识产权以及生命科学与医疗保健领域提供丰富的数据、见解和分析、工作流解决方案及专业服务 [4] 免责声明 - 该通信包含前瞻性陈述,这些陈述基于管理层当前的信念、期望和假设,涉及未来的业务、趋势、业绩等 [5] - 实际结果可能与前瞻性陈述存在重大差异,取决于多种风险因素,包括已在10-K年报中披露的风险 [5] - 公司不承诺对任何前瞻性陈述进行公开修订或更新 [5]
Clarivate (CLVT) to Develop Unified Library Solution for Ohio
ZACKS· 2024-07-23 00:10
Clarivate Plc (CLVT) recently partnered with OhioLINK and SearchOhio to integrate their INN-Reach platforms. Together, these three entities will develop a unified library solution for Ohio. The unification of OhioLINK and SearchOhio's resource platforms will enrich the database, giving the users extended choices. This partnership with OhioLINK and SearchOhio will help CLVT expand its market presence in the academic space. Clarivate provides its technology solutions to academia, government, intellectual prop ...
Clarivate Acquires Rowan TELS to Enhance Support for Patent Practitioners
Prnewswire· 2024-07-22 18:00
LONDON, July 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it has acquired Rowan TELS Corp. through a subsidiary. Rowan TELS Corp. is the provider of Rowan Patents – an integrated patent drafting and prosecution solution specially designed for patent practitioners to establish and protect patents more effectively. Gordon Samson, President, Intellectual Property, Clarivate, said: "Clarivate is committed to simplifying and optimi ...
BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX Awards
Prnewswire· 2024-07-18 15:00
LONDON, July 18, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has been honored with nine 2024 APEX Awards for Publication Excellence. This achievement underscores the BioWorld mission to deliver superior journalistic excellence, data-driven analysis and cutting-edge digital publishing. The APEX Awards, now in their 36th year, recognize outstanding work by professional communicators in areas such as graphic design, editorial ...
Clarivate to Partner with OhioLINK and SearchOhio to Create a New Unified Library Experience Across the State of Ohio
Prnewswire· 2024-07-18 15:00
LONDON, July 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a partnership with OhioLINK, Ohio's academic library consortium, and SearchOhio, a consortium of Ohio public libraries, to develop a new library resource sharing consortial experience. Erin Francoeur, Executive Director of the Westerville Public Library, which oversees the administration, technical infrastructure and consortial catalog for SearchOhio, said: "We are excit ...
Clarivate to Report Second Quarter 2024 Results on August 6, 2024
Prnewswire· 2024-07-16 21:00
LONDON, July 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2024 before the market opens on Tuesday, August 6, 2024. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. Interested parties may access the live audio broadcast by dialing +1 404-975-4839 or toll- ...